Medicare Benefits Schedule - Note PN.7.6

Where a neuromuscular disorder (NMD) is clinically suspected that is tested for using a single gene test described under items 73434 or 73435, the single gene test should be conducted prior to gene panel testing items on the Medicare Benefits Schedule (MBS).

Related Items: 73422

• Previous - Note PN.7.5
• Next - Note PN.7.7

Characterisation of a gene variant or gene variants using a gene panel, in a patient presenting with clinical signs and symptoms suggestive of a genetic neuromuscular disorder (other than signs and symptoms associated with variants that are not detected by massively parallel sequencing), if the service is requested:

(a) by a specialist or consultant physician; and

(b) after exclusion of non‑genetic causes

Applicable once per lifetime

Fee: $1,200.00 Benefit: 75% = $900.00 85% = $1,101.30

(See para PN.7.6 of explanatory notes to this Category)